{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:32:38Z","timestamp":1787589158147,"version":"build-2736575974"},"reference-count":44,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjpo"],"accepted":{"date-parts":[[2025,8,29]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study evaluated the prevalence of clinically significant drug-drug interactions (CSDDIs), off-label (OL) drug use and the associated predictors in paediatric cardiology ward.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A cross-sectional study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Hayatabad Medical Complex, Tertiary care hospital in Peshawar, Pakistan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>250 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>The Micromedex Drug-Reax tool was used to check the drug-drug interactions (DDI) and interactions of major severity were categorised as CSDDI. Association of various predictors including OL drug use with CSDDIs was evaluated using univariate and multivariate binary logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Rate of drug-drug interactions, types and classification of DDI, OL prescribing in paediatrics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Of the total 250 paediatric patients, 127 (28.6%) patients were exposed to at least one clinically significant DDI, while 228 (91.20%) patients received at least one OL prescription. Furosemide was the most frequently prescribed drug involved in CSDDIs, while it was also one of the highly prescribed OL drugs. Multivariate analysis revealed that infant age group (OR 0.256; CI 0.080 to 0.814) with p value 0.02 and patients prescribed &gt;5 drugs (OR 3.544; CI 1.906 to 6.589) were significantly more likely to experience CSDDIs in reference to their corresponding categories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A high prevalence of CSDDIs and OL prescriptions was observed. OL drug presence was also observed to be a significant predictor associated with an increased risk of CSDDIs. Thus, to improve paediatric pharmacotherapy, suitable medical interventions are required to decrease OL drug use and CSDDIs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjpo-2024-003293","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:00:17Z","timestamp":1757923217000},"page":"e003293","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of drug-drug interactions in children with cardiac disorders receiving off-label drugs in a single centre in Pakistan: a cross-sectional study"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4546-0169","authenticated-orcid":false,"given":"Anam","family":"Fatima","sequence":"first","affiliation":[{"name":"Pharmacy, The University of Lahore, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Aamir","sequence":"additional","affiliation":[{"name":"Pharmacy, The University of Lahore, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila","family":"Shahbaz","sequence":"additional","affiliation":[{"name":"Pharmacy, Sarhad University of Science & Information Technology, Peshawar, KPK, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehla","family":"Akbar","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Sciences, Khyber Medical University, Peshawar, KPK, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel","family":"Aslam","sequence":"additional","affiliation":[{"name":"MAHSA University, Federal Territory of Kuala Lumpur, Federal Territory of Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Barkat","sequence":"additional","affiliation":[{"name":"Pharmacy, The University of Lahore, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Afaq","sequence":"additional","affiliation":[{"name":"Pharmacy, The University of Lahore, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,14]]},"reference":[{"key":"2026010702021717000_9.1.e003293.1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jamacardio.2016.1326","article-title":"Recent Trends in Cardiovascular Mortality in the United States and Public Health Goals","volume":"1","author":"Sidney","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026010702021717000_9.1.e003293.2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.amjcard.2021.11.029","article-title":"Off-Label Use of Cardiovascular Drugs in the Home Therapy of Children With Congenital or Acquired Heart Disease","volume":"166","author":"Meliota","year":"2022","journal-title":"Am J Cardiol"},{"key":"2026010702021717000_9.1.e003293.3","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.clinthera.2017.07.043","article-title":"Enhancing the Pediatric Drug Development Framework to Deliver Better Pediatric Therapies Tomorrow","volume":"39","author":"Bucci-Rechtweg","year":"2017","journal-title":"Clin Ther"},{"key":"2026010702021717000_9.1.e003293.4","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12305"},{"key":"2026010702021717000_9.1.e003293.5","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-021-01303-5"},{"key":"2026010702021717000_9.1.e003293.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2019.02.001"},{"key":"2026010702021717000_9.1.e003293.7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-3487"},{"key":"2026010702021717000_9.1.e003293.8","article-title":"Polypharmacy in Pediatric Palliative Care: Exploring Discrepancies Between Physicians and Pharmacists","volume":"12","author":"Mengato","year":"2025","journal-title":"Children (Basel)"},{"key":"2026010702021717000_9.1.e003293.9","doi-asserted-by":"crossref","unstructured":"Almintakh LS , Al Dossary MF , Altesha AM , et al . Awareness, Practice, and Views of Pediatricians, General Physicians, and Pharmacists about Prescribing Off-label Medication in Pediatric Patients in Eastern Province, Saudi Arabia. Curr Pediatr Rev 2024. doi:10.2174\/0115733963298903240614072717","DOI":"10.2174\/0115733963298903240614072717"},{"key":"2026010702021717000_9.1.e003293.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-018-1370-x","article-title":"Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran","volume":"19","author":"Kouti","year":"2019","journal-title":"BMC Pediatr"},{"key":"2026010702021717000_9.1.e003293.11","article-title":"Polypharmacy in Children with Medical Complexity: A Cross-Sectional Study in a Pediatric Palliative Care Center","volume":"11","author":"Zanin","year":"2024","journal-title":"Children (Basel)"},{"key":"2026010702021717000_9.1.e003293.12","article-title":"Improving Medication Safety Through Medication Reconciliation in Pediatric Neurology: Clinical Pharmacist Recommendations and Physician Uptake in a 13-Week Study","volume":"12","author":"Zennaro","year":"2025","journal-title":"Children (Basel)"},{"key":"2026010702021717000_9.1.e003293.13","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1097\/PCC.0000000000000684","article-title":"Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children\u2019s Hospitals","volume":"17","author":"Dai","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"2026010702021717000_9.1.e003293.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246754","article-title":"Clinical significance of potential drug-drug interactions in a pediatric intensive care unit: A single-center retrospective study","volume":"16","author":"Choi","year":"2021","journal-title":"PLoS One"},{"key":"2026010702021717000_9.1.e003293.15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2015"},{"key":"2026010702021717000_9.1.e003293.16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcrc.2017.04.028","article-title":"Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study","volume":"40","author":"Ismail","year":"2017","journal-title":"J Crit Care"},{"key":"2026010702021717000_9.1.e003293.17","first-page":"2238","article-title":"Comparative assessment of drug interactions in pediatrics at private and public sector hospitals of Sargodha and Faisalabad","volume":"5","author":"Sajid","year":"2011","journal-title":"Afr J Pharm Pharmacol"},{"key":"2026010702021717000_9.1.e003293.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-018-3579-7","article-title":"Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study","volume":"18","author":"Ismail","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"2026010702021717000_9.1.e003293.19","first-page":"401","article-title":"Frequency, Levels and Predictors of Potential Drug-Drug Interactions in a Pediatrics Ward of a Teaching Hospital in Pakistan","volume":"12","author":"Ismail","year":"2013","journal-title":"Trop J Pharm Res"},{"key":"2026010702021717000_9.1.e003293.20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/pediatric14020038","article-title":"A Prospective Study of Medication Surveillance of a Pediatric Tertiary Care Hospital in Lahore, Pakistan","volume":"14","author":"Nawaz","year":"2022","journal-title":"Pediatr Rep"},{"key":"2026010702021717000_9.1.e003293.21","first-page":"14","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"81","year":"2014","journal-title":"J Am Coll Dent"},{"key":"2026010702021717000_9.1.e003293.22","doi-asserted-by":"crossref","unstructured":"Machin D , et al . Sample Sizes for Clinical, Laboratory and Epidemiology Studies. John Wiley & Sons, 2018.","DOI":"10.1002\/9781118874905"},{"key":"2026010702021717000_9.1.e003293.23","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1542\/peds.2012-0055I","article-title":"Standard 6: age groups for pediatric trials","volume":"129 Suppl 3","author":"Williams","year":"2012","journal-title":"Pediatrics"},{"key":"2026010702021717000_9.1.e003293.24","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/415815","article-title":"Off-label medicine use in pediatric inpatients: a prospective observational study at a tertiary care hospital in India","volume":"2014","author":"Saiyed","year":"2014","journal-title":"Int J Pediatr"},{"key":"2026010702021717000_9.1.e003293.25","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.4314\/tjpr.v15i10.31","article-title":"Identification of clinically significant drug-drug interactions in cardiac intensive care units of two tertiary care hospitals in Peshawar, Pakistan","volume":"15","author":"Shakeel","year":"2016","journal-title":"Trop J Pharm Res"},{"key":"2026010702021717000_9.1.e003293.26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11096-013-9764-1","article-title":"Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan","volume":"35","author":"Ismail","year":"2013","journal-title":"Int J Clin Pharm"},{"key":"2026010702021717000_9.1.e003293.27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11096-021-01346-8","article-title":"Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex\u00ae and Lexicomp\u00ae: a retrospective observational study","volume":"44","author":"Abbas","year":"2022","journal-title":"Int J Clin Pharm"},{"key":"2026010702021717000_9.1.e003293.28","doi-asserted-by":"publisher","DOI":"10.1542\/hpeds.2018-0168"},{"key":"2026010702021717000_9.1.e003293.29","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/jgs.15244","article-title":"Prevalence and Preventability of Drug-Related Hospital Readmissions: A Systematic Review","volume":"66","author":"El Morabet","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"2026010702021717000_9.1.e003293.30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/1574886313666180619120406","article-title":"Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study","volume":"13","author":"Pratico","year":"2018","journal-title":"Curr Drug Saf"},{"key":"2026010702021717000_9.1.e003293.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-005-0981-y"},{"key":"2026010702021717000_9.1.e003293.32","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-0764"},{"key":"2026010702021717000_9.1.e003293.33","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-008-9193-8"},{"key":"2026010702021717000_9.1.e003293.34","first-page":"3236","article-title":"Medication safety practice in pediatric ward","volume":"71","author":"Alqarni Mohammed","year":"2018","journal-title":"The Egyptian Journal of Hospital Medicine"},{"key":"2026010702021717000_9.1.e003293.35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jamainternmed.2015.6068","article-title":"Off-label Drug Use and Adverse Drug Events: Turning up the Heat on Off-label Prescribing","volume":"176","author":"Good","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2026010702021717000_9.1.e003293.36","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/CCM.0000000000001022","article-title":"A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs","volume":"43","author":"Smithburger","year":"2015","journal-title":"Crit Care Med"},{"key":"2026010702021717000_9.1.e003293.37","first-page":"30","article-title":"Evaluation of potential drug-drug interactions in a pediatric population","volume":"55","author":"Bebito\u011flu","year":"2020","journal-title":"Turk Pediatri Ars"},{"key":"2026010702021717000_9.1.e003293.38","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1177\/1078155219882081","article-title":"Surveillance of adverse drug reactions and drug-drug interactions with pediatric oncology patients in a south Indian tertiary care hospital","volume":"26","author":"Joseph","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"2026010702021717000_9.1.e003293.39","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11100518","article-title":"Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings","volume":"11","author":"Gerrard","year":"2019","journal-title":"Pharmaceutics"},{"key":"2026010702021717000_9.1.e003293.40","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.apjtb.2016.04.002","article-title":"Potential drug\u2013drug interactions in pediatric wards of Gondar University Hospital, Ethiopia: A cross sectional study","volume":"6","author":"Getachew","year":"2016","journal-title":"Asian Pac J Trop Biomed"},{"key":"2026010702021717000_9.1.e003293.41","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s11096-014-0011-1","article-title":"Pharmacoepidemiological study of drug\u2013drug interactions in onco-hematological pediatric patients","volume":"36","author":"Fern\u00e1ndez de Palencia Espinosa","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"2026010702021717000_9.1.e003293.42","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-060640","article-title":"Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity","volume":"151","author":"Hampl","year":"2023","journal-title":"Pediatrics"},{"key":"2026010702021717000_9.1.e003293.43","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1242779","article-title":"Impact of clinical pharmacist-led intervention for drug-related problems in neonatal intensive care unit a randomized controlled trial","volume":"14","author":"Yal\u00e7\u0131n","year":"2023","journal-title":"Front Pharmacol"},{"key":"2026010702021717000_9.1.e003293.44","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(21)00229-6"}],"container-title":["BMJ Paediatrics Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjpo-2024-003293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T10:04:01Z","timestamp":1767780241000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjpaedsopen.bmj.com\/lookup\/doi\/10.1136\/bmjpo-2024-003293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,9,14]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjpo-2024-003293"],"URL":"https:\/\/doi.org\/10.1136\/bmjpo-2024-003293","relation":{},"ISSN":["2399-9772"],"issn-type":[{"value":"2399-9772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}